Cargando…

The cisplatin-induced acute kidney injury is a novel risk factor for postoperative complications in patients with esophageal cancer: a retrospective cohort study

BACKGROUND: Cisplatin-induced acute kidney injury (AKI) is common during preoperative chemotherapy for esophageal cancer. The purpose of this study was to investigate the association between AKI after preoperative chemotherapy and postoperative complications in patients with esophageal cancer. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueno, Shuhei, Murashima, Miho, Ogawa, Ryo, Saito, Masaki, Ito, Sunao, Hayakawa, Shunsuke, Okubo, Tomotaka, Sagawa, Hiroyuki, Tanaka, Tatsuya, Takahashi, Hiroki, Matsuo, Yoichi, Mitsui, Akira, Kimura, Masahiro, Hamano, Takayuki, Takiguchi, Shuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044717/
https://www.ncbi.nlm.nih.gov/pubmed/36973771
http://dx.doi.org/10.1186/s12893-023-01949-0
_version_ 1784913415317225472
author Ueno, Shuhei
Murashima, Miho
Ogawa, Ryo
Saito, Masaki
Ito, Sunao
Hayakawa, Shunsuke
Okubo, Tomotaka
Sagawa, Hiroyuki
Tanaka, Tatsuya
Takahashi, Hiroki
Matsuo, Yoichi
Mitsui, Akira
Kimura, Masahiro
Hamano, Takayuki
Takiguchi, Shuji
author_facet Ueno, Shuhei
Murashima, Miho
Ogawa, Ryo
Saito, Masaki
Ito, Sunao
Hayakawa, Shunsuke
Okubo, Tomotaka
Sagawa, Hiroyuki
Tanaka, Tatsuya
Takahashi, Hiroki
Matsuo, Yoichi
Mitsui, Akira
Kimura, Masahiro
Hamano, Takayuki
Takiguchi, Shuji
author_sort Ueno, Shuhei
collection PubMed
description BACKGROUND: Cisplatin-induced acute kidney injury (AKI) is common during preoperative chemotherapy for esophageal cancer. The purpose of this study was to investigate the association between AKI after preoperative chemotherapy and postoperative complications in patients with esophageal cancer. METHODS: In this retrospective cohort study, we included patients who had received preoperative chemotherapy with cisplatin and underwent surgical resection for esophageal cancer under general anesthesia from January 2017 to February 2022 at an education hospital. A predictor was stage 2 or higher cisplatin-induced AKI (c-AKI) defined by the KDIGO criteria within 10 days after chemotherapy. Outcomes were postoperative complications and length of hospital stays. Associations between c-AKI and outcomes including postoperative complications and length of hospital stays were examined with logistic regression models. RESULTS: Among 101 subjects, 22 developed c-AKI with full recovery of the estimated glomerular filtration (eGFR) before surgery. Demographics were not significantly different between patients with and without c-AKI. Patients with c-AKI had significantly longer hospital stays than those without c-AKI [mean (95% confidence interval (95%CI)) 27.6 days (23.3–31.9) and 43.8 days (26.5–61.2), respectively, mean difference (95%CI) 16.2 days (4.4–28.1)]. Those with c-AKI had higher C-reactive protein (CRP) levels and prolonged weight gain after surgery and before the events of interest despite having comparable eGFR trajectories after surgery. c-AKI was significantly associated with anastomotic leakage and postoperative pneumonia [odds ratios (95%CI) 4.14 (1.30–13.18) and 3.87 (1.35–11.0), respectively]. Propensity score adjustment and inverse probability weighing yielded similar results. Mediation analysis showed that a higher incidence of anastomotic leakage in patients with c-AKI was primarily mediated by CRP levels (mediation percentage 48%). CONCLUSION: c-AKI after preoperative chemotherapy in esophageal cancer patients was significantly associated with the development of postoperative complications and led to a resultant longer hospital stay. Increased vascular permeability and tissue edema due to prolonged inflammation might explain the mechanisms for the higher incidence of postoperative complications.
format Online
Article
Text
id pubmed-10044717
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100447172023-03-29 The cisplatin-induced acute kidney injury is a novel risk factor for postoperative complications in patients with esophageal cancer: a retrospective cohort study Ueno, Shuhei Murashima, Miho Ogawa, Ryo Saito, Masaki Ito, Sunao Hayakawa, Shunsuke Okubo, Tomotaka Sagawa, Hiroyuki Tanaka, Tatsuya Takahashi, Hiroki Matsuo, Yoichi Mitsui, Akira Kimura, Masahiro Hamano, Takayuki Takiguchi, Shuji BMC Surg Research BACKGROUND: Cisplatin-induced acute kidney injury (AKI) is common during preoperative chemotherapy for esophageal cancer. The purpose of this study was to investigate the association between AKI after preoperative chemotherapy and postoperative complications in patients with esophageal cancer. METHODS: In this retrospective cohort study, we included patients who had received preoperative chemotherapy with cisplatin and underwent surgical resection for esophageal cancer under general anesthesia from January 2017 to February 2022 at an education hospital. A predictor was stage 2 or higher cisplatin-induced AKI (c-AKI) defined by the KDIGO criteria within 10 days after chemotherapy. Outcomes were postoperative complications and length of hospital stays. Associations between c-AKI and outcomes including postoperative complications and length of hospital stays were examined with logistic regression models. RESULTS: Among 101 subjects, 22 developed c-AKI with full recovery of the estimated glomerular filtration (eGFR) before surgery. Demographics were not significantly different between patients with and without c-AKI. Patients with c-AKI had significantly longer hospital stays than those without c-AKI [mean (95% confidence interval (95%CI)) 27.6 days (23.3–31.9) and 43.8 days (26.5–61.2), respectively, mean difference (95%CI) 16.2 days (4.4–28.1)]. Those with c-AKI had higher C-reactive protein (CRP) levels and prolonged weight gain after surgery and before the events of interest despite having comparable eGFR trajectories after surgery. c-AKI was significantly associated with anastomotic leakage and postoperative pneumonia [odds ratios (95%CI) 4.14 (1.30–13.18) and 3.87 (1.35–11.0), respectively]. Propensity score adjustment and inverse probability weighing yielded similar results. Mediation analysis showed that a higher incidence of anastomotic leakage in patients with c-AKI was primarily mediated by CRP levels (mediation percentage 48%). CONCLUSION: c-AKI after preoperative chemotherapy in esophageal cancer patients was significantly associated with the development of postoperative complications and led to a resultant longer hospital stay. Increased vascular permeability and tissue edema due to prolonged inflammation might explain the mechanisms for the higher incidence of postoperative complications. BioMed Central 2023-03-27 /pmc/articles/PMC10044717/ /pubmed/36973771 http://dx.doi.org/10.1186/s12893-023-01949-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ueno, Shuhei
Murashima, Miho
Ogawa, Ryo
Saito, Masaki
Ito, Sunao
Hayakawa, Shunsuke
Okubo, Tomotaka
Sagawa, Hiroyuki
Tanaka, Tatsuya
Takahashi, Hiroki
Matsuo, Yoichi
Mitsui, Akira
Kimura, Masahiro
Hamano, Takayuki
Takiguchi, Shuji
The cisplatin-induced acute kidney injury is a novel risk factor for postoperative complications in patients with esophageal cancer: a retrospective cohort study
title The cisplatin-induced acute kidney injury is a novel risk factor for postoperative complications in patients with esophageal cancer: a retrospective cohort study
title_full The cisplatin-induced acute kidney injury is a novel risk factor for postoperative complications in patients with esophageal cancer: a retrospective cohort study
title_fullStr The cisplatin-induced acute kidney injury is a novel risk factor for postoperative complications in patients with esophageal cancer: a retrospective cohort study
title_full_unstemmed The cisplatin-induced acute kidney injury is a novel risk factor for postoperative complications in patients with esophageal cancer: a retrospective cohort study
title_short The cisplatin-induced acute kidney injury is a novel risk factor for postoperative complications in patients with esophageal cancer: a retrospective cohort study
title_sort cisplatin-induced acute kidney injury is a novel risk factor for postoperative complications in patients with esophageal cancer: a retrospective cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10044717/
https://www.ncbi.nlm.nih.gov/pubmed/36973771
http://dx.doi.org/10.1186/s12893-023-01949-0
work_keys_str_mv AT uenoshuhei thecisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy
AT murashimamiho thecisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy
AT ogawaryo thecisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy
AT saitomasaki thecisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy
AT itosunao thecisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy
AT hayakawashunsuke thecisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy
AT okubotomotaka thecisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy
AT sagawahiroyuki thecisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy
AT tanakatatsuya thecisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy
AT takahashihiroki thecisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy
AT matsuoyoichi thecisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy
AT mitsuiakira thecisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy
AT kimuramasahiro thecisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy
AT hamanotakayuki thecisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy
AT takiguchishuji thecisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy
AT uenoshuhei cisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy
AT murashimamiho cisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy
AT ogawaryo cisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy
AT saitomasaki cisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy
AT itosunao cisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy
AT hayakawashunsuke cisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy
AT okubotomotaka cisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy
AT sagawahiroyuki cisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy
AT tanakatatsuya cisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy
AT takahashihiroki cisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy
AT matsuoyoichi cisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy
AT mitsuiakira cisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy
AT kimuramasahiro cisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy
AT hamanotakayuki cisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy
AT takiguchishuji cisplatininducedacutekidneyinjuryisanovelriskfactorforpostoperativecomplicationsinpatientswithesophagealcanceraretrospectivecohortstudy